“P” indicates the statistical significance of the difference between treatment and negative control (n.s. = no statistically significant difference). “Treatment/negative control” represents the rati
Additional file 3. Top gene pairs (HER2 status). This file contains raw calculated data of the top 100 gene pairs and feature selection scores for the HER2-positive and HER2-negative comparison.
Aberrant alternative splicing, prevalent in cancer, impacts various cancer hallmarks involving proliferation, angiogenesis, and invasion. Splicing disruption often results from somatic point mutations
